{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:51:49Z","timestamp":1760982709463},"reference-count":15,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ejphar.2008.06.038","type":"journal-article","created":{"date-parts":[[2008,6,15]],"date-time":"2008-06-15T19:08:23Z","timestamp":1213556903000},"page":"114-116","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Lacosamide, the new anticonvulsant, effectively reduces harmaline-induced tremors in rats"],"prefix":"10.1016","volume":"589","author":[{"given":"Thomas","family":"St\u00f6hr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Lekieffre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.06.038_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2003.10.035","article-title":"Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats","volume":"153","author":"Arshaduddin","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2008.06.038_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2007.00001.x","article-title":"Lacosamide: a review of preclinical properties","volume":"13","author":"Beyreuther","year":"2007","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejphar.2008.06.038_bib3","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/j.1528-1167.2006.00818.x","article-title":"Effects of the novel antiepileptic drug lacosamide on the development of amygdale kindling in rats","volume":"47","author":"Brandt","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2008.06.038_bib4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1592\/phco.23.10.1105.32750","article-title":"Essential tremor: diagnosis and treatment","volume":"23","author":"Chen","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2008.06.038_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nurt.2006.10.002","article-title":"Lacosamide","volume":"4","author":"Doty","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejphar.2008.06.038_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0091-3057(93)90175-S","article-title":"Effects of beta-adrenergic blockers on drug-induced tremors","volume":"44","author":"Iwata","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2008.06.038_bib7","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.39.12.1587","article-title":"Acute and chronic effects of propranolol and primidone in essential tremor","volume":"39","author":"Koller","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2008.06.038_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1474-4422(05)00991-9","article-title":"Essential tremor","volume":"4","author":"Louis","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2008.06.038_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1212\/01.wnl.0000172352.88359.2d","article-title":"Blood harmane concentrations and dietary protein consumption in essential tremor","volume":"65","author":"Louis","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2008.06.038_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/mds.20331","article-title":"Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications","volume":"20","author":"Martin","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2008.06.038_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0002-9343(03)00259-6","article-title":"Essential tremor: differential diagnosis and current therapy","volume":"115","author":"Pahwa","year":"2003","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2008.06.038_bib12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1176\/ajp.113.10.887","article-title":"Psychotomimetics, clinical and theoretical considerations: harmine, WIN-2299 and Nalline","volume":"113","author":"Pennes","year":"1957","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2008.06.038_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eplepsyres.2007.03.004","article-title":"Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy","volume":"74","author":"St\u00f6hr","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2008.06.038_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/1531-8257(199907)14:4<557::AID-MDS1004>3.0.CO;2-G","article-title":"Animal models of tremor","volume":"14","author":"Wilms","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2008.06.038_bib15","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000163769.28552.CD","article-title":"Practice parameter: therapies for essential tremor","volume":"64","author":"Zesiewicz","year":"2005","journal-title":"Neurology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908006596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908006596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T20:02:41Z","timestamp":1728417761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908006596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":15,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0014299908006596"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.06.038","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lacosamide, the new anticonvulsant, effectively reduces harmaline-induced tremors in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}